Peripheral blood dendritic cells express CD52 and are depleted in-vivo by treatment with CAMPATH-1H. by Buggins, A, Mufti, G, Fishlock, K, Arno, M, Hale, G, Waldmann, H, Pagliuca, A, Devereux, S

Induction of tumour rejection by autologous and allogeneic tumour cells expressing B7.1 and IL-2. by Hirst, W, Darling, D, Gaken, J, Buggins, A, Barnard, A, GaleaLauri, J, Kuiper, M, Hollignsworth, S, Mufti, G, Farzaneh, F

Induction of tumour rejection by B7.1 and IL-2 expressing tumour cells by Gaken, J, Hirst, W, Darling, D, GaleaLauri, J, Buggins, A, Kuiper, M, Souberbielle, B, Towner, P, Hollingsworth, S, Mufti, G, Farzaneh, F

In vitro immune modulation by antibodies coupled to tumour cells. by Darling, D, Galea-Lauri, J, Gäken, J, Towner, P, Kuiper, M, Hollingsworth, S, Hirst, W, Barnard, A, Buggins, A, Mufti, G, Farzaneh, F

Irradiated NC adenocarcinoma cells transduced with both B7.1 and interleukin-2 induce CD4+-mediated rejection of established tumors. by Gaken, J, Hollingsworth, S, Hirst, W, Buggins, A, Galea-Lauri, J, Peakman, M, Kuiper, M, Patel, P, Towner, P, Patel, P, Collins, M, Mufti, G, Farzaneh, F, Darling, D